chlorpromazine hydrochloride 50 mg
INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups. For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance.
upsher-smith laboratories, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
CHLORPROMAZINE HYDROCHLORIDE Tablets, USP, 10 mg are round, white film coated tablets, imprinted on one side with "832" above "10" and no print on the reverse side. They are supplied as follows: Bottles of 100, NDC 0832-6017-00
CHLORPROMAZINE HYDROCHLORIDE Tablets, USP, 25 mg are round, white film coated tablets, imprinted on one side with "832" above "25" and no print on the reverse side. They are supplied as follows: Bottles of 100, NDC 0832-6018-00 Bottles of 1,000, NDC 0832-6018-10
CHLORPROMAZINE HYDROCHLORIDE Tablets, USP, 50 mg are round, white film coated tablets, imprinted on one side with "832" above "50" and no print on the reverse side. They are supplied as follows: Bottles of 100, NDC 0832-6019-00 Bottles of 1,000, NDC 0832-6019-10 Unit-Dose cartons of 100, NDC 0832-6019-01 THE TABLET STRENGTHS LISTED BELOW ARE FOR USE ONLY IN SEVERE NEUROPSYCHIATRIC CONDITIONS.
CHLORPROMAZINE HYDROCHLORIDE Tablets, USP, 100 mg are round, white film coated tablets, imprinted on one side with "832" above "100" and no print on the reverse side. They are supplied as follows: Bottles of 100, NDC 0832-6020-00 Bottles of 1,000, NDC 0832-6020-10 Unit-Dose cartons of 100, NDC 0832-6020-01
CHLORPROMAZINE HYDROCHLORIDE Tablets, USP, 200 mg are round, white film coated tablets, imprinted on one side with "832" above "200" and no print on the reverse side. They are supplied as follows: Bottles of 100, NDC 0832-6021-00 Bottles of 1,000, NDC 0832-6021-10 Unit-Dose cartons of 100, NDC 0832-6021-01 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from light and moisture. This package is not for household dispensing. If dispensed for outpatient use, a well closed, light-resistant, child-resistant container should be utilized. Keep out of reach of children.
More pills like ROUND 832 50